NASDAQ:CADL | Cash Flow Statement | Candel Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$38.91M
2026-03-31-$8.86M-$18.04M$675,000.00-$675,000.00$93.82M
2025-12-31-$29.5M-$10.57M$409,000.00-$409,000.00$43.9M
2025-09-30-$11.27M
2025-06-30-$4.8M
2025-03-31$7.38M-$8.62M$3,000.00-$3,000.00-$1.87M
2024-12-31-$14.07M-$5.81M$3,000.00-$3,000.00$91.91M
2024-09-30-$10.65M
2024-06-30-$22.24M
2024-03-31-$8.22M-$8.44M$7,000.00-$7,000.00-$1.26M
2023-12-31-$11.1M-$7.42M$47,000.00-$27,000.00-$121,000.00
2023-09-30-$8.44M
2023-06-30-$9.61M
2023-03-31-$8.8M$230,000.00-$10.82M$138,000.00$19,000.00$0.00
2022-12-31-$5.08M$221,000.00-$6.89M$276,000.00-$276,000.00$36,000.00
2022-09-30-$8.69M
2022-06-30-$4.15M
2022-03-31-$874,000.00$165,000.00-$8.05M$171,000.00-$171,000.00$19.92M
2021-12-31$1.6M$178,000.00-$5.24M$504,000.00-$504,000.00$0.00
2021-09-30-$16.16M
2021-06-30-$17.08M
2021-03-31-$4.48M$26,000.00-$5.63M$229,000.00-$229,000.00$112,000.00
2020-12-31-$10.48M$6,000.00-$3.42M$453,000.00$20.18M$29,000.00
2020-09-30-$2.55M
2020-06-30-$2.88M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$38.18M-$38.31M$587,000.00-$560,000.00$56.1M
2024-12-31-$55.18M-$27.02M$16,000.00-$16,000.00$94.28M
2023-12-31-$37.94M-$34.24M$457,000.00-$280,000.00-$121,000.00
2022-12-31-$18.79M$778,000.00-$31.42M$1.3M-$1.3M$19.97M
2021-12-31-$36.12M$232,000.00-$22.22M$1.84M-$1.84M$71.8M
2020-12-31-$17.68M$91,000.00-$9.07M$1.48M$38.46M$490,000.00